Tioga Pharmaceuticals Competitors and Similar CompaniesClear all

Tioga Pharmaceuticals's competitors and similar companies include Heron Therapeutics, GBT (Global Blood Therapeutics), Melinta Therapeutics and Kamada Pharmaceuticals.
Tioga Pharmaceuticals
Tioga Pharmaceuticals
Tioga Pharmaceuticals is a company that provides a therapy for the treatment of pruritus.
Heron Therapeutics
Heron Therapeutics
Heron Therapeutics (formerly A.P. Pharma) is a biotechnology company engaged in drug discovery and development.
GBT (Global Blood Therapeutics)
GBT (Global Blood Therapeutics)
GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.
Melinta Therapeutics
Melinta Therapeutics
Melinta Therapeutics is an antibiotics-focused company that develops and commercializes antibiotics to overcome drug-resistant infections.
Kamada Pharmaceuticals
Kamada Pharmaceuticals
Kamada Pharmaceuticals is a company that develops plasma-derived protein therapeutics for orphan indications.
Founding Date
Founding Date
2005
Founding Date
1983
Founding Date
2012
Founding Date
2000
Founding Date
1990
Type
Type
Private
Type
Public
Type
Public
Type
Private
Type
Public
Tags
Locations
Locations
San Diego, US HQ
Locations
San Diego, US HQ
Locations
South San Francisco, US HQ
Paris, FR
Berlin, DE
Baar, CH
London, GB
Locations
Morristown, US HQ
New Haven, US
Locations
Rehovot, IL HQ
Beit Kama, IL
Employees
Employees
4
Employees
20333% decrease
Employees
352106% increase
Employees
1712% increase
Employees
420
Valuation ($)
Valuation ($)
N/A
Valuation ($)
268.5 m
Valuation ($)
4.4 b
Valuation ($)
N/A
Valuation ($)
317 m

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$154.9m (FY, 2025)
Revenue (est.)
$194.7m (FY, 2021)
Revenue (est.)
N/A
Revenue (est.)
$180.5m (FY, 2025)
Cost of goods
Cost of goods
N/A
Cost of goods
$41.3m (FY, 2025)
Cost of goods
$3.3m (FY, 2021)
Cost of goods
N/A
Cost of goods
$72.1m (FY, 2025)
Gross profit
Gross profit
N/A
Gross profit
$113.6m (FY, 2025)
Gross profit
N/A
Gross profit
N/A
Gross profit
$108.4m (FY, 2025)
Net income
Net income
N/A
Net income
($20.2m) (FY, 2025)
Net income
($303.1m) (FY, 2021)
Net income
N/A
Net income
$20.2m (FY, 2025)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 88.7m
Total funding raised
$ 519.2m
Total funding raised
$ 90m
For sources of this data, please see the company profile

View Company Profiles

Heron Therapeutics
HQ
San Diego, US
Employees
203↓ 33% decrease

Heron Therapeutics (formerly A.P. Pharma) is a biotechnology company engaged in drug discovery and development.

View company
GBT (Global Blood Therapeutics)
HQ
South San Francisco, US
Employees
352

GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.

View company
Melinta Therapeutics
HQ
Morristown, US
Employees
171↑ 2% increase

Melinta Therapeutics is an antibiotics-focused company that develops and commercializes antibiotics to overcome drug-resistant infections.

View company
Kamada Pharmaceuticals
HQ
Rehovot, IL
Employees
420

Kamada Pharmaceuticals is a company that develops plasma-derived protein therapeutics for orphan indications.

View company